Tag: oral urate-lowering therapy

Shanton Receives Fast Track Designation from US FDA for Refractory Gout Program

SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., July 25, 2025 /PRNewswire/ -- Shanton Pharma,...

Shanton Receives Fast Track Designation from US FDA for Refractory Gout Program

SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., July 25, 2025 /PRNewswire/ -- Shanton Pharma,...

Shanton Receives Fast Track Designation from US FDA for Refractory Gout Program

SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., July 25, 2025 /PRNewswire/ -- Shanton Pharma,...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsOral urate-lowering therapy

True Ground Housing Partners Names the Amazon Housing Fund as 2026 Affordable Housing Honoree at Celebrate Home!

Best Stylish Prescription Glasses for Work and Everyday Wear in 2026: Quay Named a Top Pick for Fashion-Forward RX Frames by Better Business Advice

AI Speeds Up Returns in Private Equity as M&A Becomes Top Value Generator for Firms

Tag: oral urate-lowering therapy

Shanton Receives Fast Track Designation from US FDA for Refractory Gout Program

Shanton Receives Fast Track Designation from US FDA for Refractory Gout Program

Shanton Receives Fast Track Designation from US FDA for Refractory Gout Program

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us